Albert Gibert Bosch

Albert Gibert Bosch serves as an Assistant Professor in the Department of Organic and Pharmaceutical Chemistry at IQS School of Engineering, Universitat Ramon Llull. He is an active member of the Pharmaceutical Chemistry Group (GQF) and has been involved in significant research projects spanning from 2014 to 2025.

His research spans multiple areas of pharmaceutical chemistry with a focus on drug discovery and development. Key research interests include molecular modeling for drug design, CXCR4 inhibitors for cancer treatment, HIV therapeutics, nanoparticle drug delivery systems, and tyrosine kinase inhibitors. His work demonstrates strong interdisciplinary connections between computational chemistry, medicinal chemistry, and cancer biology.

Recent publication trends show a consistent focus on CXCR4 targeting compounds with applications in both oncology (particularly B-cell lymphoma) and HIV treatment. His research utilizes advanced molecular modeling techniques to design novel compounds with therapeutic potential.

Dr. Bosch has participated in multiple research projects including DisX4lymph: Design and synthesis of CXCR4 allosteric inhibitors and IRAK4 degraders as potential treatments of B-cell lymphoma (2022-2025), and has been part of the Pharmaceutical Chemistry Group funded by Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR) from 2022-2025.